CRF Health, a leading global provider of ePRO solutions for the Life Sciences Industry, announced that John Harrison, PhD, had accepted an appointment as Scientific Consultant. in this role, John will provide expert advice on both patient and clinician reported outcomes in Central Nervous System (CNS) related clinical studies.

John has over 15 years of extensive experience in selection and integration of cognitive testing into drug development programs. Most recently he was Principal Scientist at CogState Ltd, a company providing cognitive testing services to pharmaceutical companies. He is also Honorary Senior Lecturer at Imperial College in London where, among other topics, he invested cognitive change as a function of disease progression in Alzheimer's disease and HIV infection. Prior to his position with CogState, John was an independent consultant to drug development companies thought CPC Pharma Services, a consultancy that services pharmaceutical and biotechnology companies.

John's education includes a BSc in Psychology from the University of Hertfordshire and a PhD in Neuroscience from the University of London. He is currently studying for a BA in Classical Studies from the Open University. He resides in the West of England with his wife Rachel and two children. In addition to his interest on the measurement of cognitive change, he enjoys ballet, opera, and studying classical civilization.

Rachael King, CEO, commented, "we are very please to have recruited Dr. Harrison in a consulting role. The world-wide aging population has triggered growing interest in Dementia and other age-related diseases. John's breadth and depth of knowledge in this area will help CRF Health develop industry-leading services for clinical trials these areas.

About CRF Health
CRF Health is a global leader in ePRO (electronic patient reported outcomes) solutions for the life sciences industry. Through innovative technology, a thorough understanding of drug development, and mobile computing, CRF Health is driving the change to higher quality outcomes and more efficient paper-free clinical trials.

CRF Health's ePRO technology has been used in more than 70 countries, on six continents and 68 regional languages, including several regional Indian dialects. CRF Health consistently demonstrates the industry's highest patient compliance rates, while delivering unrivaled data accuracy and unmatched patient and site acceptance.

Since its founding in 2000, CRF Health continues to provide true global ePRO delivery and service. Headquartered in the U.S., CRF Health operates its R&D center of excellence in Helsinki, Finland, and has offices around the world.

For more information, please visit www.crfhealth.com